Molecular therapy for Osteoporosis: The stem cell protein Oct-4 suppresses the expression of a bone formation inhibitor Sclerostin via down regulation of its target gene, 6/September/2014, 05.43 am

Insights into the development of Stress-induced T2D: Adenocorticotrophic hormone (ACTH) suppresses the expression of a positive regulator of insulin transcription, NeuroD1 via up regulation of its target gene, 6/September/2014, 05.35 am
September 6, 2014
Mechanistic insights into tumor suppression: Tumor supressor BRCA1 increases the expression of tumor suppressor LKB1 via down regulation of its target gene , 6/September/2014, 05.50 am
September 6, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Osteoporosis: The stem cell protein Oct-4 suppresses the expression of a bone formation inhibitor Sclerostin via down regulation of its target gene, 6/September/2014, 05.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that Oct-4 may promote bone mass and formation.  Thus, pharmacological formulations encompassing “Oct-4 activator” may be used to treat Osteoporosis

Comments are closed.